Summit Trail Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
12,135
+42
+0.3% +$7.41K 0.02% 731
2026
Q1
$2.17M Buy
12,093
+7,414
+158% +$1.27M 0.03% 468
2025
Q4
$663K Sell
4,679
-1,376
-23% -$156K 0.01% 997
2025
Q3
$492K Sell
6,055
-5,368
-47% -$414K 0.01% 1087
2025
Q2
$715K Buy
+11,423
New +$675K 0.01% 591
2018
Q2
Sell
-2,604
Closed -$254K 488
2018
Q1
$254K Buy
2,604
+163
+7% +$18K 0.04% 317
2017
Q4
$275K Buy
+2,441
New +$331K 0.03% 341

Other funds holding ALB

Summit Trail Advisors's ALB Position: Q2 2026 in Review

Summit Trail Advisors increased its Albemarle (ALB) stake by 0.35% in Q2 2026, buying an estimated $7.41K and bringing the position to 12,135 shares worth $1.64M. The position accounts for 0.02% of the portfolio, ranked #731.

Summit Trail Advisors first reported a position in ALB in Q4 2017 and has held it in 7 quarters since. The position peaked at $2.17M in Q1 2026. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Summit Trail Advisors held 12,135 shares of Albemarle worth $1.64M as of Q2 2026.
  • Summit Trail Advisors bought 42 Albemarle shares in Q2 2026, an estimated $7.41K.
  • Albemarle made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #731 holding.
  • Summit Trail Advisors first reported a position in Albemarle in Q4 2017 and has held it in 7 quarters since.
  • Summit Trail Advisors's Albemarle position peaked at $2.17M in Q1 2026.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.